Blood Transfusion Volume Calculator — pRBC, Platelets & FFP Dosing

How to Use This Calculator

1. Enter weight, current Hgb, and target Hgb.
2. Pediatric pRBC volume (4 mL/kg/g/dL) and adult unit estimate display instantly.
3. Use the Pediatric tab for Hct-adjusted dosing.
4. Use the Adult tab for threshold guidance by clinical setting (TRICC/TRISS thresholds).
5. Use the Platelets/FFP tab for other blood component dosing.

Formula

Example

Frequently Asked Questions

• How is pediatric blood transfusion volume calculated? ▼
  Pediatric packed red blood cell (pRBC) volume is calculated using the formula: Volume (mL) = Weight (kg) × Desired Hgb rise (g/dL) × 4. This 4 mL/kg/g/dL factor assumes a typical pRBC unit with a hematocrit of approximately 60%. If the unit hematocrit is known, a more precise formula is: Volume = Weight × Desired Hgb rise × (100 / unit Hct) × 3.3. In clinical practice, the simplified 10 mL/kg dose is commonly used as a standard starting volume, which raises hemoglobin by approximately 2-3 g/dL in most children. For neonates and premature infants, smaller incremental transfusions of 5-10 mL/kg are preferred to reduce cardiovascular loading. The maximum recommended transfusion volume per episode is typically 10-15 mL/kg to limit the risk of transfusion-associated circulatory overload (TACO). Infusion rates should not exceed 2-5 mL/kg/hr, and slower rates (1-2 mL/kg/hr) are used in haemodynamically unstable or cardiac patients. Post-transfusion hemoglobin should be checked 1 hour after completion.
• What hemoglobin level triggers a blood transfusion? ▼
  Transfusion thresholds are based on large randomised controlled trials that established the safety of restrictive strategies. For stable, non-cardiac hospitalised adults, the TRICC trial (Hebert 1999) established that a restrictive threshold of Hgb 7 g/dL is as safe as a liberal threshold of 10 g/dL and may have lower 30-day mortality. For ICU patients with septic shock, the TRISS trial (Holst 2014) confirmed that Hgb 7 g/dL is safe and reduces transfusion requirements without worsening outcomes. Patients with acute coronary syndromes or haemodynamically significant cardiac disease require a higher threshold of 8-10 g/dL, as myocardial ischaemia is exacerbated by reduced oxygen-carrying capacity. For perioperative patients, an Hgb of 8 g/dL is commonly used as the threshold, though patient-specific factors (age, comorbidities, surgical blood loss) modulate this. Paediatric thresholds also vary by age and clinical status: critically ill children in the TRIPICU trial were safely managed with a threshold of 7 g/dL. The important principle is that transfusion decisions should incorporate symptoms, haemodynamic stability, and trajectory — not hemoglobin value alone.
• Why is the pediatric transfusion formula 4 mL/kg per 1 g/dL? ▼
  The 4 mL/kg per 1 g/dL formula is derived from the physiological relationship between transfused red cell volume, blood volume, and the hematocrit of the transfused product. The average child has a blood volume of approximately 70-80 mL/kg. A pRBC unit typically has a hematocrit of around 55-65% (average 60%). If we want to raise hemoglobin by 1 g/dL, we need to add enough red cell mass to increase hemoglobin throughout the child's total blood volume. Working through the dilution calculation: Volume required = (Desired Hgb rise × Total blood volume) / Unit Hct = (1 × 75 mL/kg) / (0.60 Hct × 2.8 conversion) ≈ 4 mL/kg. The factor 4 is thus an approximation that holds reasonably well across paediatric age groups when pRBC hematocrit is in the standard 55-65% range. For neonates, who have slightly higher blood volumes per kg and may receive higher-hematocrit units, some centres use 3 mL/kg/g/dL. The formula is not applicable to adults, where the more practical "1 unit raises Hgb by approximately 1 g/dL in a 70 kg adult" rule is used.
• What is the difference between restrictive and liberal transfusion strategies? ▼
  Restrictive transfusion strategy refers to transfusing red blood cells only when hemoglobin falls below a lower threshold (typically 7-8 g/dL), whereas liberal strategy involves transfusing at higher thresholds (8-10 g/dL). Multiple randomised trials — TRICC, TRISS, FOCUS, TRICS-III — have compared these strategies across different patient populations. In general, restrictive strategies have been shown to be non-inferior to liberal strategies in most patient groups, and may be superior in some settings (e.g., gastrointestinal haemorrhage — the TRIGGER trial showed lower rebleeding rates with restrictive transfusion, partly by avoiding portal hypertension-elevating effects). Restrictive transfusion reduces exposure to transfusion-related adverse events, conserves blood supply, and lowers costs. The exception is patients with acute coronary syndromes and those with pre-existing haemodynamic compromise, where myocardial oxygen demand may warrant higher hemoglobin targets. For paediatric patients, the TRIPICU and ABC-PICU trials support restrictive strategies (Hgb threshold 7 g/dL) in stable critically ill children. Most modern blood management programmes implement restrictive strategies as the default while allowing clinician discretion for patient-specific factors.
• What are the major risks of blood transfusion? ▼
  Blood transfusion carries several categories of risk ranging from common minor reactions to rare but life-threatening complications. Febrile non-haemolytic transfusion reactions (FNHTR) are the most common, occurring in 0.5-1% of transfusions, caused by recipient antibodies against donor leukocyte antigens or cytokines in stored blood; leukoreduction significantly reduces this risk. Transfusion-associated circulatory overload (TACO) — pulmonary oedema from volume excess — occurs in 1-8% of transfusions, particularly in elderly or cardiac patients; slowing the infusion rate and using diuretics prophylactically are key preventive measures. Transfusion-related acute lung injury (TRALI) is a serious complication defined as new hypoxia within 6 hours of transfusion, caused by donor anti-HLA or anti-neutrophil antibodies; it is the leading cause of transfusion-related death and requires immediate transfusion cessation and respiratory support. Acute haemolytic reactions from ABO incompatibility are rare but catastrophic — caused by clerical errors — and require stopping the transfusion immediately. Delayed haemolytic reactions from minor antigen incompatibilities occur days later. Transfusion-transmitted infections (HIV, hepatitis B, C) are now extremely rare due to rigorous screening. Transfusion-associated graft-versus-host disease (TA-GvHD), though rare, is almost universally fatal and prevented by irradiating blood products for immunocompromised recipients.

Related Calculators